ArticleDiscover oncology2025
Granular acute lymphocytic leukemia : a case report and literature review.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Acute lymphoblastic leukemia (ALL) is a malignant disease characterized by the clonal proliferation of precursor lymphoblasts in the bone marrow. Granular acute lymphoblastic leukemia (G-ALL) is a rare subtype of ALL, primarily associated with B-cell lineage. Traditionally, cytoplasmic granules indicate myeloid leukemia cell differentiation, as primitive lymphoblasts typically lack cytoplasmic granules. Therefore, the immature lymphoblasts in G-ALL may be mistaken for granular myeloid progenitor cells, causing potential diagnostic errors. The involvement of the BCOR gene in acute lymphoblastic leukemia has not been well-documented. This study examines the clinical data of a G-ALL patient, reviews relevant literature, and aims to improve disease recognition among clinicians and laboratory personnel, enhance diagnostic accuracy, and reduce instances of misdiagnosis and mistreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.